首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   61378篇
  免费   6959篇
  国内免费   4598篇
耳鼻咽喉   490篇
儿科学   612篇
妇产科学   604篇
基础医学   7358篇
口腔科学   1206篇
临床医学   8062篇
内科学   9375篇
皮肤病学   614篇
神经病学   3482篇
特种医学   2257篇
外国民族医学   52篇
外科学   6310篇
综合类   11040篇
现状与发展   19篇
一般理论   5篇
预防医学   4217篇
眼科学   1853篇
药学   6836篇
  37篇
中国医学   3424篇
肿瘤学   5082篇
  2024年   90篇
  2023年   1065篇
  2022年   1476篇
  2021年   2991篇
  2020年   2586篇
  2019年   2242篇
  2018年   2260篇
  2017年   2095篇
  2016年   1982篇
  2015年   2986篇
  2014年   3707篇
  2013年   3168篇
  2012年   4933篇
  2011年   5319篇
  2010年   3146篇
  2009年   2436篇
  2008年   3366篇
  2007年   3242篇
  2006年   3179篇
  2005年   3128篇
  2004年   2049篇
  2003年   1985篇
  2002年   1629篇
  2001年   1387篇
  2000年   1428篇
  1999年   1632篇
  1998年   989篇
  1997年   946篇
  1996年   685篇
  1995年   644篇
  1994年   643篇
  1993年   394篇
  1992年   563篇
  1991年   427篇
  1990年   390篇
  1989年   326篇
  1988年   317篇
  1987年   252篇
  1986年   218篇
  1985年   181篇
  1984年   99篇
  1983年   60篇
  1982年   45篇
  1981年   41篇
  1980年   19篇
  1979年   42篇
  1978年   15篇
  1977年   14篇
  1964年   7篇
  1936年   8篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
目的了解ICU护士预防呼吸机相关性肺炎集束化护理方案临床实施不佳的原因,为护理管理提供参考。方法采用质性研究的现象学方法,对在我中心ICU工作1年以上的19名护理人员进行深入访谈,按现象学研究方法整理分析资料。结果通过阅读、分析、反思、分类,提炼4个主题,包括病情限制不能实施相关护理、低学历低年资护士缺乏业务知识和临床经验、护理任务繁重而人员相对短缺的困扰、医嘱执行中的不规范问题。结论 ICU护士预防呼吸机相关性肺炎集束化护理方案实施不佳的主要原因有多方面,需引起护理管理者的重视,采取有效应对来促进护理质量持续改进。  相似文献   
82.
对19例宫颈癌治疗后继发性双下肢淋巴水肿患者行手法引流综合消肿治疗,包括手法淋巴引流、弹性绷带包扎、功能锻炼等,治疗1个疗程,患者下肢周径较治疗前明显减小、水肿程度减轻,皮肤肿胀感与肢体沉重感均减轻,皮肤纤维化程度明显降低,临床症状显著改善,住院16~23 d出院。提出加强双下肢水肿的评估、皮肤护理、手法淋巴引流的护理、绷带包扎护理、功能锻炼指导、心理护理及延续护理,可提高双下肢淋巴水肿患者治疗效果。  相似文献   
83.

Background

Glutamine addiction is a hallmark of clear cell renal cell carcinoma (ccRCC); yet whether glutamine metabolism impacts local immune surveillance is unclear. This knowledge may yield novel immunotherapeutic opportunities.

Objective

To seek a potential therapeutic target in glutamine-addicted ccRCC.

Design, setting, and participants

Tumors from ccRCC patients from a Shanghai cohort and ccRCC tumor data from The Cancer Genome Atlas (TCGA) cohort were analyzed. In vivo and in vitro studies were conducted with fresh human ccRCC tumors and murine tumor cells.

Outcome measurements and statistical analysis

Immune cell numbers and functions were analyzed by flow cytometry. Glutamine and cytokine concentrations were determined. Survival was compared between different subpopulations of patients using Kaplan-Meier and Cox regression analyses.

Results and limitations

We found that in ccRCC, high interleukin (IL)-23 expression was significantly associated with poor survival in both TCGA (overall survival [OS] hazard ratio [HR] = 2.04, cancer-specific survival [CSS] HR = 2.95; all p < 0.001) and Shanghai (OS HR = 2.07, CSS HR = 3.92; all p < 0.001) cohorts. IL-23 blockade prolongs the survival of tumor-bearing mice, promotes T-cell cytotoxicity in in vitro cultures of human ccRCC tumors, and augments the therapeutic benefits of anti-PD-1 antibodies. Mechanistically, glutamine consumption by ccRCC tumor cells results in the local deprivation of extracellular glutamine, which induces IL-23 secretion by tumor-infiltrating macrophages via the activation of hypoxia-inducible factor 1α (HIF1α). IL-23 activates regulatory T-cell proliferation and promotes IL-10 and transforming growth factor β expression, thereby suppressing tumor cell killing by cytotoxic lymphocytes. The positive correlations between glutamine metabolism, IL-23 levels, and Treg responses are confirmed in both TCGA cohort and tumors from Shanghai ccRCC patients. Study limitations include the unclear impacts of glutamine deprivation and IL-23 on other immune cells.

Conclusions

Macrophage-secreted IL-23 enhanced Treg functions in glutamine-addicted tumors; thus, IL-23 is a promising target for immunotherapy in ccRCC.

Patient summary

In this study, we analyzed the immune components in glutamine-addicted clear cell renal cell carcinoma (ccRCC) tumors from two patient cohorts and conducted both in vitro and in vivo studies. We found that ccRCC tumor cell-intrinsic glutamine metabolism orchestrates immune evasion via interleukin (IL)-23, and IL-23–high patients had significantly poorer survival than IL-23–low patients. IL-23 should thus be considered a therapeutic target in ccRCC, either alone or in combination with immune checkpoint inhibitors.  相似文献   
84.
Ferroptosis is an iron-dependent novel cell death pathway. Deferoxamine, a ferroptosis inhibitor, has been reported to promote spinal cord injury repair. It has yet to be clarified whether ferroptosis inhibition represents the mechanism of action of Deferoxamine on spinal cord injury recovery. A rat model of Deferoxamine at thoracic 10 segment was established using a modified Allen's method. Ninety 8-week-old female Wistar rats were used. Rats in the Deferoxamine group were intraperitoneally injected with 100 mg/kg Deferoxamine 30 minutes before injury. Simultaneously, the Sham and Deferoxamine groups served as controls. Drug administration was conducted for 7 consecutive days. The results were as follows:(1) Electron microscopy revealed shrunken mitochondria in the spinal cord injury group.(2) The Basso, Beattie and Bresnahan locomotor rating score showed that recovery of the hindlimb was remarkably better in the Deferoxamine group than in the spinal cord injury group.(3) The iron concentration was lower in the Deferoxamine group than in the spinal cord injury group after injury.(4) Western blot assay revealed that, compared with the spinal cord injury group, GPX4, xCT, and glutathione expression was markedly increased in the Deferoxamine group.(5) Real-time polymerase chain reaction revealed that, compared with the Deferoxamine group, mRNA levels of ferroptosis-related genes Acyl-CoA synthetase family member 2(ACSF2) and iron-responsive element-binding protein 2(IREB2) were up-regulated in the Deferoxamine group.(6) Deferoxamine increased survival of neurons and inhibited gliosis. These findings confirm that Deferoxamine can repair spinal cord injury by inhibiting ferroptosis. Targeting ferroptosis is therefore a promising therapeutic approach for spinal cord injury.  相似文献   
85.
Cerebral ventricular infection(CVI) is one of the most dangerous complications in neurosurgery because of its high mortality and disability rates. Few studies have examined the application of neuroendoscopic surgical techniques(NESTs) to assess and treat CVI. This multicenter, retrospective study was conducted using clinical data of 32 patients with CVI who were assessed and treated by NESTs in China. The patients included 20 men and 12 women with a mean age of 42.97 years. NESTs were used to obliterate intraventricular debris and pus, fenestrate or incise the intraventricular compartment and reconstruct cerebrospinal fluid circulation, and remove artificial material. Intraventricular irrigation with antibiotic saline was applied after neuroendoscopic surgery(NES). Secondary hydrocephalus was treated by endoscopic third ventriculostomy or a ventriculoperitoneal shunt. Neuroendoscopic findings of CVI were used to classify patients into Grade I(n = 3), Grade II(n = 13), Grade III(n = 10), and Grade IV(n = 6) CVI. The three patients with grade I CVI underwent one NES,the 23 patients with grade II/III CVI underwent two NESs, and patients with grade IV CVI underwent two(n = 3) or three(n = 3) NESs.The imaging features and grades of neuroendoscopy results were positively related to the number of neurosurgical endoscopic procedures.Two patients died of multiple organ failure and the other 30 patients fully recovered. Among the 26 patients with secondary hydrocephalus,18 received ventriculoperitoneal shunt and 8 underwent endoscopic third ventriculostomy. There were no recurrences of CVI during the 6-to 76-month follow-up after NES. Application of NESTs is an innovative method to assess and treat CVI, and its neuroendoscopic classification provides an objective, comprehensive assessment of CVI. The study trial was approved by the Institutional Review Board of Beijing Shijitan Hospital, Capital Medical University, China.  相似文献   
86.
87.
88.
89.
90.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号